•  Home
  • Library
  • DRO home
Submit research Contact DRO

DRO

High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial.

Patten, RK, McIlvenna, LC, Levinger, I, Garnham, AP, Shorakae, S, Parker, AG, McAinch, AJ, Rodgers, RJ, Hiam, Danielle, Moreno-Asso, A and Stepto, NK 2022, High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial., Hum Reprod, doi: 10.1093/humrep/deac047.


Title High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial.
Author(s) Patten, RK
McIlvenna, LC
Levinger, I
Garnham, AP
Shorakae, S
Parker, AG
McAinch, AJ
Rodgers, RJ
Hiam, Danielle
Moreno-Asso, A
Stepto, NK
Journal name Hum Reprod
Publisher p
Place of publication England
Publication date 2022-03-23
ISSN 1460-2350
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Obstetrics & Gynecology
Reproductive Biology
exercise
high-intensity interval training
moderate-intensity continuous training
PCOS
insulin resistance
menstrual cycle
TYPE-2 DIABETES-MELLITUS
INSULIN-RESISTANCE
PHYSICAL-EXERCISE
OBESE WOMEN
CARDIOMETABOLIC DISEASE
INTERVAL EXERCISE
BODY-COMPOSITION
GLUCOSE
OVERWEIGHT
PROGRAM
Summary STUDY QUESTION: Does 12 weeks of high-intensity interval training (HIIT) result in greater improvements in cardio-metabolic and reproductive outcomes compared to standard moderate-intensity continuous training (MICT) in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: HIIT offers greater improvements in aerobic capacity, insulin sensitivity and menstrual cyclicity, and larger reductions in hyperandrogenism compared to MICT. WHAT IS KNOWN ALREADY: Exercise training is recognized to improve clinical outcomes in women with PCOS, but little is known about whether HIIT results in greater health outcomes compared to standard MICT. STUDY DESIGN, SIZE, DURATION: This was a two-armed randomized clinical trial enrolling a total of 29 overweight women with PCOS between May 2016 and November 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with PCOS aged 18-45 years were randomly assigned to 12 weeks of either MICT (60-75% peak heart rate, N = 14) or HIIT (>90% peak heart rate, N = 15), each completed three times per week. The primary clinical outcomes were aerobic capacity (VO2peak) and insulin sensitivity (euglycaemic-hyperinsulinaemic clamp). Secondary outcomes included hormonal profiles, menstrual cyclicity and body composition. MAIN RESULTS AND THE ROLE OF CHANCE: Both HIIT and MICT improved VO2peak (HIIT; Δ 5.8 ± 2.6 ml/kg/min, P < 0.001 and MICT; Δ 3.2 ± 2 ml/kg/min, P < 0.001), however, the HIIT group had a greater improvement in aerobic capacity compared to MICT (β = 2.73 ml/kg/min, P = 0.015). HIIT increased the insulin sensitivity index compared to baseline (Δ 2.3 ± 4.4 AU, P = 0.007) and MICT (β = 0.36 AU, P = 0.030), and caused higher increases in sex hormone-binding globulin compared to MICT (β = 0.25 nmol/l, P = 0.002). HIIT participants were 7.8 times more likely to report improved menstrual cyclicity than those in the MICT group (odds ratio 7.8, P = 0.04). LIMITATIONS, REASONS FOR CAUTION: This study has a small sample size and the findings of the effect of the exercise interventions are limited to overweight reproductive-aged women, who do not have any co-existing co-morbidities that require medication. WIDER IMPLICATIONS OF THE FINDINGS: Exercise, regardless of intensity, has clear health benefits for women with PCOS. HIIT appears to be a more beneficial strategy and should be considered for promoting health and reducing cardio-metabolic risk in overweight women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a Project Support Grant from the Australian National Health and Medical Research Council (NHMRC) Centre for Research Excellence in PCOS. The authors have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: ACTRN12615000242527. TRIAL REGISTRATION DATE: 19 February 2015. DATE OF FIRST PATIENT’S ENROLMENT: 27 May 2016.
Language eng
DOI 10.1093/humrep/deac047
Indigenous content off
Field of Research 11 Medical and Health Sciences
16 Studies in Human Society
Persistent URL http://hdl.handle.net/10536/DRO/DU:30166618

Document type: Journal Article
Collections: Faculty of Health
School of Exercise and Nutrition Sciences
Related Links
Link Description
Connect to published version
Go to link with your DU access privileges
 
Author URL
Go to link with your DU access privileges
 
Connect to Elements publication management system
Go to link with your DU access privileges
 
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus Google Scholar Search Google Scholar
Access Statistics: 5 Abstract Views  -  Detailed Statistics
Created: Tue, 12 Apr 2022, 08:15:54 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.